InterCure Ltd.
INCR.TA - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$13.57B
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $13.57 Billion |
|---|---|
| Enterprise Value | $13.71 Billion |
| Earnings per Share | $-3.15 |
| Beta | 0.64 |
| Outstanding Shares | 10,137,256 |
Return
| Return on Equity | -9.01% |
|---|---|
| Return on Assets | -5.17% |
| Return on Invested Capital | -14.12% |
Valuation & Multiples
| P/E Ratio | -4.06 |
|---|---|
| PEG | 7.98 |
| Price to Sales | 51.5 |
| Price to Book Ratio | 34.33 |
| Enterprise Value to Revenue | 50.74 |
| Enterprise Value to EBIT | -203.9 |
| Enterprise Value to Net Income | -384 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.46 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Intercure Ltd
285 employees
CEO: Alexander Rabinovitch
InterCure Ltd. operates as an investment holding company, with interests in the medical cannabis, biomedicine, life sciences, technology, and medical devices fields. It operates through the Investments in Biomed Portfolio Companies segme...